Skip to content

Evaluation of medicinal use of Tukhm-e-Suddab (seeds of Ruta graveolens) in management of Atherosclerosis

Evaluation of Efficacy of Tukhm Suddab (Ruta graveolens) in Atherosclerosis - A Randomized Single Blind Placebo Control Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/03/012714
Enrollment
40
Registered
2018-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Apparently healthy, but diagnosed as atherosclerosis according to the periscope scale.

Interventions

Intervention1: Tukhm Suddab (Ruta graveolens) single herb in powdered form.: Test group treated with three capsules twice a day (each capsule contain 1 gm powder of test drug) for 90 days. Control Int

Sponsors

Natioinal Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: (a) Patient of either sex (b) Patients of age 25-60 years (c) Peripheral arterial diseases (PAD) (d) ABI 80.

Exclusion criteria

Exclusion criteria: (a) Uncontrolled diabetes (HbA1c > 9) and hypertension (160 110 mm of Hg) (b) Severe systemic diseases like chronic kidney disease or congestive heart failure etc. (c) Pregnant and lactating women (d) Patient who fails to follow up or give consent.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Unani single drug Tukhme Suddab (seeds of Ruta graveolens) by assessing changes in Periscope (Ankle Brachial Index and Arterial Stiffness Index).Timepoint: Ankle Brachial Index (ABI): Oth, 30th,60th and 90th day. Arterial Stiffness Index (ASI): Oth, 30th,60th and 90th day.

Secondary

MeasureTime frame
Lipid profile includes cholesterol, triglyceride, HDL, and LDLTimepoint: Lipid profile: Oth, 30th,60th and 90th day.

Countries

India

Contacts

Public ContactTanzeel Ahmad

Ajmal Khan Tibbiya College, Aligarh Muslim University, Aligarh

tanzeel_ahmad@rediffmail.com8791901465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026